Metsera, Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Metsera, Inc. and other ETFs, options, and stocks.About MTSR
Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o.
MTSR Key Statistics
Stock Snapshot
Metsera, Inc.(MTSR) stock is priced at $83.60, giving the company a market capitalization of 8.76B.
During the trading session on 2025-11-07, Metsera, Inc.(MTSR) shares reached a daily high of $83.86 and a low of $80.30. At a current price of $83.60, the stock is +4.1% higher than the low and still -0.3% under the high.
Trading volume for Metsera, Inc.(MTSR) stock has reached 1.9M, versus its average volume of 4.78M.
The stock's 52-week range extends from a low of $12.30 to a high of $83.86.
The stock's 52-week range extends from a low of $12.30 to a high of $83.86.
MTSR News
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...
New insider activity at Metsera, Inc. ( (MTSR) ) has taken place on November 5, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...